Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma

Salles, G; Dlugosz-Danecka, M; Ghesquieres, H; Jurczak, W

Dlugosz-Danecka, M (corresponding author), Maria Sklodowska Curie Natl Res Inst Oncol, Dept Clin Oncol, Krakow, Poland.

EXPERT OPINION ON BIOLOGICAL THERAPY, ; ():

Abstract

Introduction Patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) require further treatment options, especially in cases tha......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索